文献速递耳科与耳神经鼻科

梅尼埃病与偏头痛:偏头痛药物对梅尼埃病症状的影响

Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease.
PubMed 文献 · Laryngoscope · 2026-04-21

基于TriNetX数据库的回顾性队列研究显示,偏头痛患者发生梅尼埃病(MD)及相关症状的风险更高;在接受偏头痛治疗的患者中,MD发生率反而高于未治疗者(RR=0.43提示未治疗者风险更低),但未治疗者耳鸣风险略增。

要点

  • 偏头痛患者5年后及超过5年发生MD及相关症状的风险增加。
  • 未接受偏头痛治疗的偏头痛患者发生MD的风险低于接受治疗者(RR=0.43)。
  • 未治疗者耳鸣风险略增(RR=1.11),听力下降和耳闷无显著差异。

核心结论

  • 偏头痛与梅尼埃病存在关联,支持偏头痛与前庭耳蜗功能障碍的病理生理联系。

研究设计与样本

  • 回顾性队列研究,使用TriNetX数据库2013年至2025年数据,比较非偏头痛与偏头痛患者、偏头痛治疗与未治疗患者,并进行倾向性评分匹配。

主要发现

  • 偏头痛患者在索引日期后5年及超过5年时MD及相关症状发生率更高。
  • 在偏头痛患者中,未治疗者发生MD的风险比接受治疗者低(RR=0.43,95%CI:0.28-0.66)。
  • 未治疗与治疗亚组间听力下降或耳闷发生率无显著差异。
  • 未接受治疗的偏头痛患者发生耳鸣的风险增加(RR=1.11,95%CI:1.03-1.19)。

临床怎么用

  • 对偏头痛患者应关注梅尼埃病相关症状的监测,尤其是接受偏头痛治疗者。
  • 偏头痛治疗与MD发生风险的关联需进一步研究,不应据此改变偏头痛治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To observe the incidence of Meniere's disease (MD) and MD-related symptoms (i.e., aural fullness, tinnitus, hearing loss, and vertigo) between (a) non-migraine and migraine patients and (b) migraine untreated and migraine treated patients within the TriNetX database. METHODS: We conducted a retrospective cohort study of (a) non-migraine and migraine patients and (b) migraine treated and untreated patients within the TriNetX database from 2013 till 2025. Patients underwent propensity score matching for sex, age, race, and known lifestyle/disease confounders for MD. Incidence of MD and MD-related symptoms were evaluated 5 years post index date and beyond 5 years post index date. RESULTS: Migraine patients demonstrated a greater incidence of MD and MD-related symptoms 5 years and more than 5 years post index date. Amongst migraine patients, those not receiving treatment demonstrated a lesser predilection (risk ratio [RR] = 0.43, 95% CI: 0.28-0.66) of developing MD than patients receiving treatment. There was no significant difference in the incidence of hearing loss or aural fullness between migraine untreated and treated subgroups. Migraine patients not receiving treatment had an increased risk of experiencing tinnitus (RR = 1.11, 95% CI: 1.03-1.19). CONCLUSIONS: There exists a connection between migraine and MD. Migraine patients receiving migraine treatment are statistically significantly more likely to develop MD compared to non-migraine patients. These results support the findings of preceding studies that have demonstrated a pathophysiological link between migraine and vestibulocochlear dysfunction.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Bhatt K, Ren Y, Chan C, et al. Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease. Laryngoscope. 2026. PMID: 42018740. doi:10.1002/lary.70578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。